首页|TREM2在肝细胞癌中的表达与预后、免疫浸润及药物敏感性的分析

TREM2在肝细胞癌中的表达与预后、免疫浸润及药物敏感性的分析

扫码查看
目的 基于生物信息学的方法分析肝细胞癌患者中髓系细胞触发受体2(TREM2)基因表达水平与预后、免疫微环境及化疗药物敏感性的关联.方法 基于癌症基因组图谱(TCGA)、基因表达综合数据库(GEO)和国际癌症基因组联合体(ICGC)数据库分析TREM2在肝细胞癌组织中的表达差异;分析TREM2高、低表达组与肝细胞癌生存预后及免疫浸润的相关性;然后对TREM2进行GO和KEGG、突变和药物敏感性分析.结果 TREM2在肿瘤组织中的表达水平明显高于正常组织(P<0.001);TREM2高表达组患者的总生存率(OS)显著低于低表达组(P<0.05).突变分析发现TP53基因在TREM2高表达组具有更高的突变频率.免疫分析结果表明TREM2的表达与肝细胞癌基质评分(r=0.36,P<0.001)、免疫评分(r=0.55,P<0.001)和ESTIMATE评分(r=0.50,P<0.001)成正相关;与调节性T细胞(Tregs)、M2型巨噬细胞的免疫浸润水平成正相关(P<0.001).KEGG和GO富集分析显示,TREM2基因在细胞吞噬、肝癌细胞转移、免疫逃逸、炎症反应等生物学过程通路上高度富集.药物敏感性分析发现,TREM2高表达组有较高敏感性的药物有索拉非尼、帕博利珠单抗、西罗莫司、硼替佐米和拉帕替尼(P<0.05).结论 TREM2高表达的患者预后较差,且与免疫细胞浸润、肿瘤微环境有关,并有望成为肝细胞癌治疗的新靶点.
TREM2 expression in hepatocellular carcinoma and its correlation with prognosis,immune infiltration,and drug sensitivity
Objective To analyze the association between TREM2 gene expression level and prognosis,immune microenvironment,and drug sensitivity in chemotherapy in patients with hepatocellular carcinoma.Methods Data from The Cancer Genome Atlas(TCGA),the Gene Expression Omnibus(GEO),and the International Cancer Genome Consortium(ICGC)databases were collected and TREM2 expression differences in the hepatocellular carcinoma tissues were also conducted.We analyzed the correlation between TREM2 high and low expression groups with regards to hepatocellular carcinoma survival prognosis and immune infiltration.We analyzed GO and KEGG enrichment,mutation,and drug sensitivity for TREM2.Results The expression level of TREM2 in the tumor tissues was significantly higher than that in the normal tissues(P<0.001).The overall survival rate(OS)of patients in the high TREM2 expression group was significantly lower than that in the low expression group(P<0.05).Mutation analysis revealed a higher mutation frequency of the TP53 gene in the high TREM2 expression group.Immune analysis results indicated a positive correlation between TREM2 expression and the hepatocellular carcinoma stroma score(r=0.36,P<0.001),the immune score(r=0.55,P<0.001),and the ESTIMATE score(r=0.50,P<0.001).TREM2 expression was also positively correlated with immune infiltration levels of regulatory T cells(Tregs)and M2 macrophages(P<0.001).KEGG and GO enrichment analysis showed that the TREM2 gene was highly enriched in biological pathways related to cell phagocytosis,hepatocellular carcinoma cell migration,immune evasion,and inflammatory response.Drug sensitivity analysis identified increased sensitivity to drugs such as sorafenib,pembrolizumab,regorafenib,bortezomib,and apatinib in the high TREM2 expression group(P<0.05).Conclusion Patients with high TREM2 expression have poor prognosis,which is associated with immune cell infiltration and tumor microenvironment,and expected to be a new target for hepatocellular carcinoma treatment.

hepatocellular carcinomaTREM2bioinformaticstumor microenvironmentdrug sensitivity

王文榜、冯佳宁、解辉平、王淼、余克富、张志斐、于德红

展开 >

华北理工大学,河北 唐山 063000

首都医科大学附属北京天坛医院,北京 100071

肝细胞癌 TREM2 生物信息 肿瘤微环境 药物敏感性

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(4)
  • 21